You are here
Autoimmune Technologies, LLC
UEI: NBLGCCAQXG85
# of Employees: 10
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Double Chimeric Peptide Vaccine Feasible for Human Use that Protects against Disseminated Candidiasis caused by medically important Candida species
Amount: $224,645.00PROJECT ABSTRACT The goal of this Phase I STTR proposal is to develop and establish preclinical proof of concept for the first double chimeric peptide vaccine feasible for human use that protects agai ...
STTRPhase I2018Department of Health and Human Services National Institutes of Health -
Peptide inhibitors of coronavirus entry
Amount: $225,000.00DESCRIPTION (provided by applicant): The broad long-term objectives of the proposed work are to develop effective medical countermeasures to be used for the treatment of viral infectious disease cause ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
Peptide inhbitors of influenza entry-FAST TRACK
Amount: $2,633,980.00DESCRIPTION (provided by applicant): Between 10% and 20% of the United State population suffer from seasonal influenza each year. While most individuals recover from influenza in one to two weeks, the ...
SBIRPhase II2010Department of Health and Human Services National Institutes of Health -
Peptide inhbitors of influenza entry-FAST TRACK
Amount: $1,304,710.00DESCRIPTION (provided by applicant): Between 10% and 20% of the United State population suffer from seasonal influenza each year. While most individuals recover from influenza in one to two weeks, the ...
SBIRPhase I2009Department of Health and Human Services National Institutes of Health -
Peptide drugs against influenza virus
Amount: $922,901.00DESCRIPTION (provided by applicant): Influenza virus is one of the most important human pathogens accounting for widespread morbidity and mortality. Influenza virus is currently classified as a NIAID ...
STTRPhase I2006Department of Health and Human Services National Institutes of Health -
Development of molecular diagnostic assays for systemic autoimmune diseases
Amount: $99,838.00DESCRIPTION (provided by applicant): We aim to produce a significantly improved diagnostic system for autoimmune, rheumatologic disease. Similarities between autoimmune diseases and HIV-induced diseas ...
STTRPhase I2006Department of Health and Human Services National Institutes of Health -
Development of molecular diagnostic assays for systemic autoimmune diseases
Amount: $99,838.00DESCRIPTION (provided by applicant): We aim to produce a significantly improved diagnostic system for autoimmune, rheumatologic disease. Similarities between autoimmune diseases and HIV-induced diseas ...
SBIRPhase I2006Department of Health and Human Services National Institutes of Health -
Peptide drugs against influenza virus
Amount: $922,901.00DESCRIPTION (provided by applicant): Influenza virus is one of the most important human pathogens accounting for widespread morbidity and mortality. Influenza virus is currently classified as a NIAID ...
SBIRPhase I2006Department of Health and Human Services National Institutes of Health -
DIAGNOSTIC TEST FOR CHRONIC FATIGUE AND FIBROMYALGIA
Amount: $65,690.00The long-term goal is to demonstrate that the Anti-Polymer Antibody Assay is diagnostic for chronic fatigue syndrome patients and fibromyalgia patients. In a pilot study 55 % (6/11) of chronic fatigue ...
SBIRPhase I1997Department of Health and Human Services
